{"id":11611,"date":"2014-05-02T04:29:56","date_gmt":"2014-05-02T04:29:56","guid":{"rendered":"https:\/\/clone.arsacs.com\/collaboration-de-genzyme-au-projet-arsacs\/"},"modified":"2026-03-16T18:07:25","modified_gmt":"2026-03-16T22:07:25","slug":"collaboration-de-genzyme-au-projet-arsacs","status":"publish","type":"post","link":"https:\/\/arsacs.com\/fr\/collaboration-de-genzyme-au-projet-arsacs\/","title":{"rendered":"Collaboration de Genzyme au projet ARSACS"},"content":{"rendered":"L'\u00e9quipe ARSACS et les repr\u00e9sentants de Genzyme, une biotechnologie m\u00e9dicale d\u00e9di\u00e9e aux maladies rares, se sont entendus le 17 avril 2014 \u00e0 Montr\u00e9al pour travailler en collaboration sur le projet de recherche ARSACS. Genzyme est une soci\u00e9te de la compagnie pharmaceutique multinationale fran\u00e7aise Sanofi.\n\n<img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-thumbnail wp-image-293\" src=\"https:\/\/arsacs.com\/wordpress\/wp-content\/uploads\/2016\/04\/group-150x150.jpg\" alt=\"group\" width=\"150\" height=\"150\" \/>\n(de g\u00e0 dr) Dr Peter McPherson, Dr Kalle Gehring, Dr Bernard Brais, Jean Groleau, Dr Lamya Shihaubuddin (Genzyme), Sonia Gobeil, Dr Anne McKinney, Dr Richard Gregory (Genzyme).\n\n<img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-thumbnail wp-image-294\" src=\"https:\/\/arsacs.com\/wordpress\/wp-content\/uploads\/2016\/04\/group2-150x150.jpg\" alt=\"group2\" width=\"150\" height=\"150\" \/>\n(g \u00e0 dr) Sonia Gobeil, Dr Lamya Shihaubuddin, Dr Richard Gregory et Jean Groleau.\n\nLa Fondation travaille en collaboration avec G\u00e9nome Canada et les Instituts de recherche en sant\u00e9 du Canada en fournissant un appui financier \u00e0 la recherche pour d\u00e9velopper un traitement pour l' ARSACS.","protected":false},"excerpt":{"rendered":"<p>L&#8217;\u00e9quipe ARSACS et les repr\u00e9sentants de Genzyme, une biotechnologie m\u00e9dicale d\u00e9di\u00e9e aux maladies rares, se sont entendus le 17 avril 2014 \u00e0 Montr\u00e9al pour travailler en collaboration sur le projet de recherche ARSACS. Genzyme est une soci\u00e9te de la compagnie pharmaceutique multinationale fran\u00e7aise Sanofi. (de g\u00e0 dr) Dr Peter McPherson, Dr Kalle Gehring, Dr Bernard [&#8230;]<\/p>\n","protected":false},"author":3,"featured_media":9145,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["post-11611","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-partenariats"],"_links":{"self":[{"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/posts\/11611","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/comments?post=11611"}],"version-history":[{"count":1,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/posts\/11611\/revisions"}],"predecessor-version":[{"id":24107,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/posts\/11611\/revisions\/24107"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/media\/9145"}],"wp:attachment":[{"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/media?parent=11611"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/categories?post=11611"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/tags?post=11611"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}